Biology Reference
In-Depth Information
Kovats S, Main EK, Librach C, Stubblebine M, Fisher SJ, DeMars R (1990) A class I antigen,
HLA-G, expressed in human trophoblasts. Science 248:220-223
Krmpotic A, Messerle M, Crnkovic-Mertens I, Polic B, Jonjic S, Koszinowski UH (2001) The
immunoevasive function encoded by the mouse cytomegalovirus gene m152 protects the virus
against T cell control in vivo. J Exp Med 190:1285-1296
Krmpotic A, Busch DH, Bubic I, Gebhardt F, Hengel H, Hasan M, Scalzo AA, Koszinowski UH,
Jonjic S (2002) MCMV glycoprotein gp40 confers virus resistance to CD8+ T cells and NK
cells in vivo. Nat Immunol 3:529-535
Krmpotic A, Bubic I, Polic B, Lucin P, Jonjic S (2003) Pathogenesis of murine cytomegalovirus
infection. Microbes Infect 5:1263-1277
Kropff B, Mach M (1997) Identification of the gene coding for rhesus cytomegalovirus glycoprotein
B and immunological analysis of the protein. J Gen Virol 78:1999-2007
Kuhn EM, Stolte N, Matz-Rensing K, Mach M, Stahl-Henning C, Hunsmann G, Kaup FJ
(1999) Immunohistochemical studies of productive rhesus cytomegalovirus infection in rhe-
sus monkeys (Macaca mulatta) infected with simian immunodeficiency virus. Vet Pathol
36:51-56
Kurz S, Steffens HP, Mayer A, Harris JR, Reddehase MJ (1997) Latency versus persistence or
intermittent recurrences: evidence for a latent state of murine cytomegalovirus in the lungs.
J Virol 71:2980-2987
Kurz SK, Rapp M, Steffens HP, Grzimek NK, Schmalz S, Reddehase MJ (1999) Focal transcrip-
tional activity of murine cytomegalovirus during latency in the lungs. J Virol 73:482-494
La Rosa C, Limaye AP, Krishnan A, Longmate J, Diamond DJ (2007) Longitudinal assessment of
cytomegalovirus (CMV)-specific immune responses in liver transplant recipients at high risk
for late CMV disease. J Infect Dis 195:633-644
Lacey SF, Gallez-Hawkins G, Crooks M, Martinez J, Senitzer D, Forman SJ, Spielberger R, Zaia
JA, Diamond DJ (2002) Characterization of cytotoxic function of CMV-pp65-specific CD8+
T-lymphocytes identified by HLA tetramers in recipients and donors of stem-cell transplants.
Transplantation 74:722-732
Lang DJ, Kummer JF (1975) Cytomegalovirus in semen: observations in selected populations.
J Infect Dis 132:472-473
Lanier LL (1999) Natural killer cells fertile with receptors for HLA-G? Proc Natl Acad Sci USA
96:5343-5345
Lathey JL, Fiscus SA, Rasheed S, Kappes JC, Griffith BP, Elbeik T, Spector SA, Reichelderfer PS
(1994) Optimization of quantitative culture assay for human immunodeficiency virus from
plasma. Plasma Viremia Group Laboratories of the AIDS Clinical Trials Group (National
Institute of Allergy and Infectious Diseases). J Clin Microbiol 32:3064-3067
Lautenschlager I, Soots A, Krogerus L, Kauppinen H, Saarinen O, Bruggeman C, Ahonen J (1997)
CMV increases inflammation and accelerates chronic rejection in rat kidney allografts.
Transplant Proc 29:802-803
Lautenschlager I, Halme L, Hockerstedt K, Krogerus L, Taskinen E (2006) Cytomegalovirus
infection of the liver transplant: virological, histological, immunological, and clinical observa-
tions. Transpl Infect Dis 8:21-30
Lawrence RM, Lawrence RA (2004) Breast milk and infection. Clin Perinatol 31:501-528
Le Bouteiller P (2000) HLA-G in the human placenta: expression and potential functions.
Biochem Soc Trans 28:208-212
Lemstrom K, Persoons M, Bruggeman C, Ustinov J, Lautenschlager I, Hayry P (1993)
Cytomegalovirus infection enhances allograft arteriosclerosis in the rat. Transplant Proc
25:1406-1407
Lemstrom K, Sihvola R, Bruggeman C, Hayry P, Koskinen P (1997) Cytomegalovirus infection-
enhanced cardiac allograft vasculopathy is abolished by DHPG prophylaxis in the rat.
Circulation 95:2614-2616
Lenfant F, Pizzato N, Liang S, Davrinche C, Le Bouteiller P, Horuzsko A (2003) Induction of
HLA-G-restricted human cytomegalovirus pp65 (UL83)-specific cytotoxic T lymphocytes in
HLA-G transgenic mice. J Gen Virol 84:307-317
